GlycoMimetics to Report Fourth Quarter and 2022 Full Year Financial Results on March 29, 2023

Rhea-AI Summary

GlycoMimetics, Inc. (Nasdaq: GLYC) will host a conference call and webcast on March 29, 2023, at 8:30 a.m. ET to discuss its fourth quarter and 2022 full-year financial results. Investors can access the call via a registration link. A live webcast will be available on the company’s website, with a replay accessible for 30 days after the call. GlycoMimetics focuses on developing glycobiology-based therapies for cancers and inflammatory diseases.

Positive

• Upcoming conference call to discuss fourth quarter and 2022 financial results may indicate transparency and investor engagement.
• Focus on developing therapies for high unmet needs could attract interest and funding.

Negative

• None.

ROCKVILLE, Md.--(BUSINESS WIRE)-- GlycoMimetics, Inc. (Nasdaq: GLYC), today announced that it will host a conference call and webcast to report fourth quarter and 2022 full year financial results on Wednesday, March 29, 2023, at 8:30 a.m. ET.

To access the call by phone, please go to this registration link and you will be provided with dial in details. Participants are encouraged to connect 15 minutes in advance of the scheduled start time.

A live webcast of the call will be available on the “Investors” tab on the GlycoMimetics website. A webcast replay will be available for 30 days following the call.

About GlycoMimetics, Inc.

GlycoMimetics is a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers, including AML, and for inflammatory diseases with high unmet needs. The company’s science is based on an understanding of the role that carbohydrates play in cell recognition and its specialized chemistry platform to discover small molecule drugs, known as glycomimetics, which alter carbohydrate-mediated recognition in diverse disease states, including cancer and inflammation. As a leader in this science, GlycoMimetics leverages this unique approach to advance its pipeline of wholly-owned drug candidates, with the goal of developing transformative therapies for diseases with high unmet need. GlycoMimetics is headquartered in Rockville, MD in the BioHealth Capital Region. Learn more at www.glycomimetics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230316005228/en/

Investor Contact:

Argot Partners

Leo Vartorella

212-600-1902

Glycomimetics@argotpartners.com

Source: GlycoMimetics, Inc.

FAQ

When will GlycoMimetics report its fourth quarter and full year 2022 financial results?

GlycoMimetics will report its financial results on March 29, 2023.

What time is GlycoMimetics' conference call on March 29, 2023?

The conference call is scheduled for 8:30 a.m. ET.

How can I access the GlycoMimetics conference call?

You can access the call via a registration link provided in the press release.

Is there a webcast available for the GlycoMimetics conference call?

Yes, a live webcast will be available on GlycoMimetics' website.

Will a replay of the GlycoMimetics conference call be available?

Yes, a webcast replay will be accessible for 30 days after the call.